Balmana J, Fasching PA, Couch FJ, Delaloge S, et al. Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast Cancer Res Treat 2023 Dec 19. doi: 10.1007/s10549-023-07165.
PMID: 38112922